FDA Sees Child Shot Benefit; Singapore Work Access: Virus Update

https://www.bloomberg.com/news/articles/2021-10-23/fda-sees-child-shot-benefit-singapore-work-access-virus-update
The benefits of the Covid-19 vaccine by Pfizer Inc. and BioNTech SE for children ages 5 to 11 are likely to outweigh the risks, according to a U.S. Food and Drug Administration staff analysis ahead of an advisory panel meeting next week.